Phenolic indeno[1,2-b]indoles as ABCG2-selective potent and non-toxic inhibitors stimulating basal ATPase activity
暂无分享,去创建一个
Mathieu Marchivie | Joachim Jose | Jean Guillon | A. di Pietro | Evelyn Winter | Myléne Honorat | J. Jose | M. Marchivie | N. Pinaud | Attilio Di Pietro | Mylène Honorat | M. Le Borgne | G. Valdameri | Glaucio Valdameri | Evelyn Winter | Z. Bouaziz | Marc Le Borgne | Nathalie Guragossian | Gustavo Jabor Gozzi | Zouhair Bouaziz | Nathalia Daflon-Yunes | Christelle Marminon | Andre Bollacke | Noël Pinaud | Silvia M Cadena | J. Guillon | S. M. Cadena | G. Gozzi | Nathalia Daflon-Yunes | N. Guragossian | Christelle Marminon | A. Bollacke | S. Cadena
[1] M. Schroeder. The University of Göttingen , 2018, Nature.
[2] H. Zimmer,et al. Oxidations with potassium nitrosodisulfonate (Fremy's radical). Teuber reaction. , 1971 .
[3] R L Juliano,et al. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.
[4] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[5] M. Sainsbury,et al. The Coupling Reactions of 3-Acylindoles and Proof of Structure of the Palladium (II) Acetane Mediated Cyclisation Reaction Product of 3-Benzoyl-1-methylindole , 1983 .
[6] O. Issinger,et al. Isolation and characterization of recombinant human casein kinase II subunits α and β from bacteria , 1991 .
[7] A. Duncan,et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.
[8] L. Doyle,et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[9] Vincenzo,et al. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. , 1998, Cancer research.
[10] S. Rabindran,et al. Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C. , 1998, Cancer research.
[11] T. Litman,et al. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. , 1999, Cancer research.
[12] T. Litman,et al. Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells. , 2001, Biochemical and biophysical research communications.
[13] J. Schellens,et al. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. , 2002, Molecular cancer therapeutics.
[14] M. Gottesman. Mechanisms of cancer drug resistance. , 2002, Annual review of medicine.
[15] E. Georges,et al. A mechanism for P-glycoprotein-mediated apoptosis as revealed by verapamil hypersensitivity. , 2003, Biochemistry.
[16] M. Gottesman,et al. Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.
[17] Joachim Jose,et al. Synthesis and Biological Evaluation of 3-(Substituted-benzylidene)-1,3-dihydro-indolin Derivatives as Human Protein Kinase CK2 and p60c-Src Tyrosine Kinase Inhibitors , 2007 .
[18] L. Szente,et al. Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporter. , 2007, Biochimica et biophysica acta.
[19] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.
[20] A. Schinkel,et al. Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice. , 2009, Advanced drug delivery reviews.
[21] M. Gottesman,et al. Is resistance useless? Multidrug resistance and collateral sensitivity. , 2009, Trends in pharmacological sciences.
[22] Richard J. Gildea,et al. OLEX2: a complete structure solution, refinement and analysis program , 2009 .
[23] H. Uno,et al. Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999. , 2010, Blood.
[24] C. Götz,et al. A CE‐based assay for human protein kinase CK2 activity measurement and inhibitor screening , 2010, Electrophoresis.
[25] S. Bates,et al. The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan. , 2011, European journal of cancer.
[26] R. Callaghan,et al. P-glycoprotein inhibition: the past, the present and the future. , 2011, Current drug metabolism.
[27] Veerababurao Kavala,et al. An Easy Access to Carbazolones and 2,3-Disubstituted Indoles , 2011 .
[28] P. Carrupt,et al. Targeting the multidrug ABCG2 transporter with flavonoidic inhibitors: in vitro optimization and in vivo validation. , 2011, Current medicinal chemistry.
[29] Jérôme Guitton,et al. Substituted chromones as highly potent nontoxic inhibitors, specific for the breast cancer resistance protein. , 2012, Journal of medicinal chemistry.
[30] F. Totzke,et al. Novel indeno[1,2-b]indoloquinones as inhibitors of the human protein kinase CK2 with antiproliferative activity towards a broad panel of cancer cell lines. , 2012, Biochemical and biophysical research communications.
[31] A. di Pietro,et al. Methoxy stilbenes as potent, specific, untransported, and noncytotoxic inhibitors of breast cancer resistance protein. , 2012, ACS chemical biology.
[32] F. Totzke,et al. Indeno[1,2-b]indole derivatives as a novel class of potent human protein kinase CK2 inhibitors. , 2012, Bioorganic & medicinal chemistry.
[33] Zhaohui J. Cai,et al. Pretreatment data is highly predictive of liver chemistry signals in clinical trials , 2012, Drug design, development and therapy.
[34] D. Ross,et al. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. , 2012, Biochemical pharmacology.
[35] G. Szakács,et al. Structure-activity relationships of chromone derivatives toward the mechanism of interaction with and inhibition of breast cancer resistance protein ABCG2. , 2013, Journal of medicinal chemistry.
[36] J. Jose,et al. Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2. , 2013, European journal of medicinal chemistry.
[37] A. di Pietro,et al. Symmetric bis-chalcones as a new type of breast cancer resistance protein inhibitors with a mechanism different from that of chromones. , 2014, Journal of medicinal chemistry.
[38] A. di Pietro,et al. MBL-II-141, a chromone derivative, enhances irinotecan (CPT-11) anticancer efficiency in ABCG2-positive xenografts , 2014, Oncotarget.
[39] M. Gottesman,et al. Targeting the Achilles Heel of Multidrug-Resistant Cancer by Exploiting the Fitness Cost of Resistance , 2014, Chemical reviews.
[40] Joachim Jose,et al. Converting potent indeno[1,2-b]indole inhibitors of protein kinase CK2 into selective inhibitors of the breast cancer resistance protein ABCG2. , 2015, Journal of medicinal chemistry.